Shilpa medicare to produce 5 crore doses of Sputnik V by 2022
The information was verified by Sputnik V via its official Twitter handle.
The information was verified by Sputnik V via its official Twitter handle.
The Gam-COVID-Vac combined vector vaccine (Component I & Component II) has been developed by National Research Center for Epidemiology and Microbiology of the Ministry of Health of the Russian Federation, Moscow, Russia and is approved in 30 countries across the world.
"The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests and was produced for civilian circulation.
